Page last updated: 2024-10-25

deferoxamine and Congenital Erythropoietic Porphyria

deferoxamine has been researched along with Congenital Erythropoietic Porphyria in 2 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Research Excerpts

ExcerptRelevanceReference
"Congenital erythropoietic porphyria is a rare autosomal recessive disorder of haem biosynthesis caused by a deficiency of uroporphyrinogen III synthetase."1.31Congenital erythropoietic porphyria: dilemmas in present day management. ( Creamer, JD; Dawe, SA; Du Vivier, A; Peters, TJ, 2002)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dawe, SA1
Peters, TJ1
Du Vivier, A1
Creamer, JD1
Lange, B1
Hofweber, K1
Waldherr, R1
Schärer, K1

Other Studies

2 other studies available for deferoxamine and Congenital Erythropoietic Porphyria

ArticleYear
Congenital erythropoietic porphyria: dilemmas in present day management.
    Clinical and experimental dermatology, 2002, Volume: 27, Issue:8

    Topics: Adult; Anemia, Hemolytic; Blood Transfusion; Bone Diseases; Deferoxamine; Female; Hematopoietic Stem

2002
Congenital erythropoietic porphyria associated with nephrotic syndrome and renal siderosis.
    Acta paediatrica (Oslo, Norway : 1992), 1995, Volume: 84, Issue:11

    Topics: Anti-Inflammatory Agents; Child; Deferoxamine; Glomerular Filtration Rate; Humans; Iron Chelating Ag

1995